Alphonso Nichols, MD
Psychiatry · San Diego, CANPI 1003890666
Payments from drug & device makers
Across 36 payments — averaging $215.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$5K
- Sunovion Pharmaceuticals Inc.$2K
- Teva Pharmaceuticals USA, Inc.$113
- Otsuka America Pharmaceutical, Inc.$73
- Takeda Pharmaceuticals U.S.A., Inc.$56
- Tris Pharma Inc$48
- plus $101 from 4 others
What the payments were for
- Consulting fees$4,00052%
- Speaking & faculty fees$2,21729%
- Travel & lodging$6849%
- Food & beverage$75710%
- Education$991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 11 | $5,013 |
| Sunovion Pharmaceuticals Inc. | 8 | $2,353 |
| Teva Pharmaceuticals USA, Inc. | 2 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $56 |
| Tris Pharma Inc | 2 | $48 |
| Neurocrine Biosciences, Inc. | 1 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Adlon Therapeutics L.p. | 2 | $24 |
| Neos Therapeutics, LP | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$4,806
- LATUDA$2,217
How this compares
$7,756 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 12 | $28,657 |
| BelsomraSuvorexant | 11 | $4,951 |
| Lurasidone Hcl | 15 | $2,828 |
| Aripiprazole | 54 | $2,558 |
| Divalproex Sodium ErDivalproex Sodium | 24 | $1,384 |
| Bupropion XlBupropion Hcl | 84 | $1,362 |
| Quetiapine Fumarate | 110 | $1,151 |
| Atomoxetine Hcl | 16 | $808 |
| Trazodone Hcl | 111 | $741 |
| Olanzapine | 14 | $654 |
| Sertraline Hcl | 144 | $648 |
| Mirtazapine | 60 | $598 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $588 |
| Duloxetine Hcl | 38 | $568 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 49 | $532 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in San Diego
- Eric ChavezSan Diego$15.5M
- Charmaine SemeniukSan Diego$8.9M
- Jonathan MeyerSan Diego$2.3M
- Vishaal MehraSan Diego$1M
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.